<DOC>
	<DOCNO>NCT01644084</DOCNO>
	<brief_summary>It advantageous use 5 % human albumin ( HA ) patient undergo cardiopulmonary bypass ( CPB ) , preexposure synthetic surface CPB circuit albumin decrease coagulopathy , platelet aggregation , immune response . However use albumin limit , expensive rarely cause infection . Hydroxyethyl starch ( HES ) decrease clot strength prolong clot formation . A recently develop 6 % HES 130/0.4 know few effect hemostasis . However Schramlo AA et al . report short time infusion HES 130/0.4 cardiac surgery produce impairment fibrin formation clot strength thromboelastometry tracing . Coagulopathy directly relate bleed massive postoperative bleeding increase risk reoperation . Therefore important avoid administration fluid inhibit homeostasis CPB . The purpose study investigate effect 6 % HES 130/0.4 component prim solution coagulation compare 5 % HA .</brief_summary>
	<brief_title>A Comparison Between 5 % Albumin 6 % Hydroxyethyl Starch 130/0.4 Priming Solution Cardiopulmonary Bypass Post-bypass Maintenance Fluid High-risk Patients</brief_title>
	<detailed_description />
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>patient uncontrolled medical problem , lifethreatening cardiac disease , complex cardiac surgery , emergency operation patient receive warfarin , heparin , acetylsalicylic acid , antiplatelet drug within 5 day surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>albumin</keyword>
	<keyword>hydroxyethyl starch 130/0.4</keyword>
	<keyword>cardiopulmonary bypass</keyword>
</DOC>